Crispr Therapeutics shares tumble after significant earnings miss
Thomas J. Shaw, President and CEO of Retractable Technologies Inc . (NYSE:RVP), has recently increased his stake in the company by purchasing additional shares. According to a recent SEC filing, Shaw acquired a total of 21,883 shares of common stock over two consecutive days, May 12 and May 13, 2025. The purchases amounted to a total value of $16,492, with the price per share ranging from $0.7522 to $0.7546. With the current stock price at $0.78 and a market capitalization of $22.6 million, InvestingPro analysis suggests the stock is trading below its Fair Value, though investors should note the stock’s high volatility with a beta of 1.65. Following these transactions, Shaw’s direct ownership in the company increased to 15,286,250 shares.
In addition to his direct holdings, Shaw also has indirect control over 831,600 shares, including 500,000 shares held in trust for a family member, reflecting his substantial voting and investment influence in the company. The transactions were executed under a Rule 10b5-1 trading plan adopted on August 22, 2024.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.